ReiThera expands large-scale viral vector production capabilities with opening of new manufacturing facility
New 1,500 sq.m. facility granted operational authorisation from AIFA, the Italian Medicines Agency, to enable production scales of up to 3,000 liters; New facility will allow ReiThera to [...]
